NASDAQ:CHB Global X China Biotech Innovation ETF (CHB) Price, Holdings, & News → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free CHB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$6.64▼$6.6450-Day Range$6.64▼$6.6752-Week Range$6.63▼$10.07VolumeN/AAverage Volume712 shsMarket Capitalization$1.39 millionAssets Under Management$1.41 millionDividend Yield0.45%Net Expense Ratio0.67% Stock AnalysisStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial MediaStock AnalysisDividendHeadlinesHoldingsRatingsShort InterestSocial Media Get Global X China Biotech Innovation ETF alerts: Email Address About Global X China Biotech Innovation ETF (NASDAQ:CHB)The Global X China Biotech Innovation ETF (CHB) is an exchange-traded fund that is based on the Solactive China Biotech Innovation index. The fund tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry. CHB was launched on Sep 22, 2020 and is managed by Global X.Read More Ad GoldenCrest MetalsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.Learn More Now CHB ETF News HeadlinesFebruary 26, 2024 | investing.comGlobal X China Electric Vehicle and Battery ETF (9845)December 29, 2023 | msn.comGlobal X China Biotech Innovation ETF declares semi-annual distribution of $0.0019April 24, 2024 | GoldenCrest Metals (Ad)Emergency: Biden's $20 Trillion Mistake Could Cost YOU!The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.December 4, 2023 | wsj.comThis Chinese Biotech Stock Just Fell 24%November 18, 2023 | investing.comCHIE ETF Stock Price HistorySeptember 26, 2023 | benzinga.comBiotechnology Contract Manufacturing Market worth $24.8 billion | MarketsandMarketsSeptember 8, 2023 | benzinga.comCGTN: China's northeast region to advance revitalization via tech innovationAugust 21, 2023 | wsj.comBeijing Bohui Innovation Biotechnology Group Co. Ltd. AApril 24, 2024 | GoldenCrest Metals (Ad)Emergency: Biden's $20 Trillion Mistake Could Cost YOU!The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.July 28, 2023 | investing.comGlobal X China Biotech USD (9820)See More Headlines Receive CHB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X China Biotech Innovation ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerGlobal X Fund NameGlobal X China Biotech Innovation ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CHB Inception Date9/22/2020 Fund ManagerChang Kim, Nam To, Wayne Xie, Kimberly Chan WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive China Biotech Innovation Index CategoryStrategy FocusTheme Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings2 Fund Statistics Assets Under Management$1.41 million Average Daily Volume$0.00 Discount/Premium-0.07% Administrator, Advisor and Custodian AdministratorGlobal X Management Company LLC AdvisorGlobal X Management Company LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerSusquehanna Options OptionableN/A Short Interest8,800 shs Miscellaneous Outstanding Shares210,000Beta0.29 Creation Unit50,000 Creation Fee$600.00 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Ad GoldenCrest MetalsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.Learn More Now Global X China Biotech Innovation ETF ExpensesTypeCHBTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.65%0.57%0.54%0.48%0.51%Other Expenses0.02%0.72%0.54%0.34%0.58%Total Expense0.67%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.76%-0.55%-0.22%-0.57%Net Expense0.67%0.59%0.60%0.54%0.58% Global X China Biotech Innovation ETF (CHB) HoldingsTop 10 CHB HoldingsWuXi Biologics (Cayman) IncHolding Weight: 8.87%Changchun High and New Technology Industry Group Inc Class AHolding Weight: 7.91%Chongqing Zhifei Biological Products Co Ltd Class AHolding Weight: 7.71%Walvax Biotechnology Co Ltd Class AHolding Weight: 7.60%CSPC Pharmaceutical Group LtdHolding Weight: 7.18%Shanghai RAAS Blood Products Co Ltd Class AHolding Weight: 4.94%Beijing Tiantan Biological Products Corp Ltd Class AHolding Weight: 4.76%Hualan Biological Engineering Inc Class AHolding Weight: 4.58%Sichuan Kelun Pharmaceutical Co Ltd Class AHolding Weight: 4.33%Zai Lab(NASDAQ:ZLAB)Holding Weight: 4.11%Full Holdings Details Similar ETFsThemes Cybersecurity ETFNASDAQ:SPAMFirst Trust Indxx Metaverse ETFNASDAQ:ARVRVanEck Green Infrastructure ETFNASDAQ:RNEWStrategy Shares Halt Climate Change ETFNASDAQ:NZRORoundhill Daily 2X Long Magnificent Seven ETFNASDAQ:MAGX CHB ETF - Frequently Asked Questions How often does Global X China Biotech Innovation ETF pay dividends? What is the dividend yield for Global X China Biotech Innovation ETF? Global X China Biotech Innovation ETF declared a Semi-Annual dividend on Wednesday, December 27th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.002 per share on Monday, January 8th. The ex-dividend date is Thursday, December 28th. Read our dividend analysis for CHB. What does CHB invest in? Global X China Biotech Innovation ETF is a equity fund issued by Global X. CHB focuses on theme investments and follows the Solactive China Biotech Innovation Index. The fund's investments total to approximately $1.41 million assets under management. What is the management fee for Global X China Biotech Innovation ETF? Global X China Biotech Innovation ETF's management fee is 0.65% and has other expenses of 0.02%. The net expense ratio for CHB is 0.67%. This page (NASDAQ:CHB) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe Greatest Bull Market in Crypto History…Weiss RatingsNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X China Biotech Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
